IOL CHEMICALS & PHARM. | DECIPHER LABS | IOL CHEMICALS & PHARM./ DECIPHER LABS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.8 | -2.3 | - | View Chart |
P/BV | x | 1.6 | 0.7 | 222.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. DECIPHER LABS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
DECIPHER LABS Mar-23 |
IOL CHEMICALS & PHARM./ DECIPHER LABS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 63 | 851.9% | |
Low | Rs | 272 | 14 | 1,937.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 45.1 | 836.9% | |
Earnings per share (Unadj.) | Rs | 23.7 | -2.7 | -892.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -2.2 | -1,413.6% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 23.0 | 1,117.6% | |
Shares outstanding (eoy) | m | 58.71 | 10.10 | 581.3% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 0.9 | 125.4% | |
Avg P/E ratio | x | 17.1 | -14.5 | -117.6% | |
P/CF ratio (eoy) | x | 12.8 | -17.3 | -74.3% | |
Price / Book Value ratio | x | 1.6 | 1.7 | 93.9% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 389 | 6,102.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 412 | 408.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 456 | 4,865.0% | |
Other income | Rs m | 256 | 74 | 347.4% | |
Total revenues | Rs m | 22,427 | 529 | 4,236.1% | |
Gross profit | Rs m | 2,257 | -106 | -2,124.8% | |
Depreciation | Rs m | 462 | 4 | 10,785.0% | |
Interest | Rs m | 165 | 5 | 3,417.0% | |
Profit before tax | Rs m | 1,887 | -42 | -4,535.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -15 | -3,352.1% | |
Profit after tax | Rs m | 1,391 | -27 | -5,187.9% | |
Gross profit margin | % | 10.2 | -23.3 | -43.7% | |
Effective tax rate | % | 26.2 | 35.5 | 73.9% | |
Net profit margin | % | 6.3 | -5.9 | -106.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 201 | 4,813.3% | |
Current liabilities | Rs m | 5,025 | 50 | 10,139.6% | |
Net working cap to sales | % | 20.9 | 33.2 | 63.1% | |
Current ratio | x | 1.9 | 4.1 | 47.5% | |
Inventory Days | Days | 43 | 30 | 143.7% | |
Debtors Days | Days | 8 | 789 | 1.1% | |
Net fixed assets | Rs m | 11,017 | 71 | 15,574.5% | |
Share capital | Rs m | 587 | 101 | 581.3% | |
"Free" reserves | Rs m | 14,490 | 131 | 11,053.6% | |
Net worth | Rs m | 15,077 | 232 | 6,496.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 272 | 7,616.1% | |
Interest coverage | x | 12.5 | -7.6 | -163.2% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 1.7 | 63.9% | |
Return on assets | % | 7.5 | -8.1 | -92.8% | |
Return on equity | % | 9.2 | -11.6 | -79.9% | |
Return on capital | % | 13.6 | -15.8 | -85.9% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -16 | -7,812.8% | |
From Investments | Rs m | -1,200 | -43 | 2,806.4% | |
From Financial Activity | Rs m | -41 | -22 | 191.2% | |
Net Cashflow | Rs m | -18 | -80 | 23.0% |
Indian Promoters | % | 48.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 16.4 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | - | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 83.6 | 62.0% | |
Shareholders | 130,003 | 33,371 | 389.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | COMBAT DRUGS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.84% | 0.00% | -0.33% |
1-Month | 6.42% | 2.15% | -0.42% |
1-Year | -1.58% | -17.23% | 53.28% |
3-Year CAGR | -12.79% | -20.28% | 14.79% |
5-Year CAGR | 17.57% | -8.10% | 19.71% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the COMBAT DRUGS share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of COMBAT DRUGS the stake stands at 16.4%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of COMBAT DRUGS.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
COMBAT DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of COMBAT DRUGS.
For a sector overview, read our pharmaceuticals sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.